Volume 7, Issue 2

Rapid ART: Benefits and Clinical Considerations

In this issue:

Rapid ART — initiating ART as soon as possible after an HIV diagnosis: How effective is it at bringing people with newly diagnosed HIV into lasting care? When and how should it be initiated? Are there particular populations where attempting rapid ART should be avoided? 

Join us as we discuss these issues with Dr. Jonathan Colasanti from Atlanta’s Emory University and Grady Health System, in this eHIV Review podcast.

Learning objectives:

  • Explain when and how to initiate rapid ART. 
  • Discuss aspects of the HIV care continuum that may be improved through rapid ART in a variety of populations.

Author:

Jonathan A. Colasanti, MD, MSPH
Jonathan A. Colasanti, MD, MSPH
Associate Professor of Medicine
Emory School of Medicine
Medical Director
The Infectious Disease Program (HIV) Ponce de Leon Center,
Grady Health System
Atlanta, GA

Program Directors:

Justin Alves, RN, FNP-BC, ACRN, CARN, CNE

Nurse Educator
Boston Medical Center
Boston, MA
(he/him/his)

Matthew Spinelli, MD, MAS

Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California
(he/him/his)

Ethel D. Weld, MD, PhD

Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland
(she/her/hers)

Length of activity:

0.5 hour Physicians
0.5 contact hour Nurses

Launch date: January 6, 2022
Expiration date: January 5, 2024